PharmaCyte Biotech Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Cash & Equivalents	68.04	85.4	2.2	0.89	0.52	1.06	3.46	1.92	2.7	3.62	Upgrade
Cash & Cash Equivalents	68.04	85.4	2.2	0.89	0.52	1.06	3.46	1.92	2.7	3.62	Upgrade
Cash Growth	-20.33%	3778.14%	146.08%	73.67%	-51.38%	-69.41%	80.35%	-28.85%	-25.35%	1714.56%	Upgrade
Other Current Assets	0.11	0.09	0.07	0.14	0.14	0.22	0.07	0.11	1.47	0.57	Upgrade
Total Current Assets	68.15	85.49	2.28	1.04	0.65	1.28	3.54	2.03	4.17	4.19	Upgrade
Long-Term Investments	1.57	1.57	1.57	1.57	1.57	1.57	1.57	1.57	1.57	1.57	Upgrade
Goodwill and Intangibles	3.55	3.55	3.55	3.55	3.55	3.55	3.55	3.55	3.55	3.55	Upgrade
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	Upgrade
Total Long-Term Assets	5.13	5.13	5.13	5.13	5.13	5.13	5.13	5.13	5.13	5.13	Upgrade
Total Assets	73.28	90.62	7.4	6.17	5.78	6.41	8.67	7.16	9.3	9.32	Upgrade
Accounts Payable	0.13	0.21	0.17	0.19	0.12	0.35	0.37	0.34	0.5	0.33	Upgrade
Current Debt	0	0	0	0.03	0	0	0	0	0	0	Upgrade
Other Current Liabilities	0.46	0.5	0.55	0.82	0.62	0.29	0.21	0.3	1.02	0.04	Upgrade
Total Current Liabilities	0.59	0.7	0.72	1.03	0.74	0.64	0.58	0.64	1.52	0.37	Upgrade
Long-Term Debt	0	0	0	0.05	0	0	0	0	0	0	Upgrade
Total Long-Term Liabilities	0	0	0	0.05	0	0	0	0	0	0	Upgrade
Total Liabilities	0.59	0.7	0.72	1.08	0.74	0.64	0.58	0.64	1.52	0.37	Upgrade
Total Debt	0	0	0	0.08	0	0	0	0	0	0	Upgrade
Retained Earnings	-115.96	-111.65	-107.41	-103.86	-100.03	-95.96	-89.14	-84.69	-78.63	-68.7	Upgrade
Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.01	-0	0	0	0	0	Upgrade
Shareholders' Equity	72.69	89.92	6.68	5.09	5.04	5.77	8.09	6.52	7.78	8.94	Upgrade
Net Cash / Debt	68.04	85.4	2.2	0.82	0.52	1.06	3.46	1.92	2.7	3.62	Upgrade
Net Cash / Debt Growth	-20.33%	3778.14%	168.66%	59.08%	-51.38%	-69.41%	80.35%	-28.85%	-25.35%	-	Upgrade
Net Cash Per Share	3.49	5.50	1.52	0.91	0.70	1.64	6.15	3.83	5.75	9.30	Upgrade
Working Capital	67.56	84.79	1.55	0.01	-0.09	0.64	2.96	1.39	2.65	3.81	Upgrade
Book Value Per Share	3.73	5.79	4.61	5.63	6.87	8.93	14.35	13.00	16.56	23.00	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).